跳至主要内容
临床试验/NCT06672692
NCT06672692招募中不适用

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

DiaSorin Molecular LLC6 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2024年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
6
主要终点
Diagnostic Accuracy

研究概览

简要总结

The DiaSorin Molecular LIAISON® NES FLU A/B, RSV & COVID-19 real-time polymerase chain reaction (RT-PCR) assay is intended for use on the DiaSorin LIAISON® NES instrument for the in-vitro qualitative detection and differentiation of nucleic acid from influenza A, influenza B, RSV and SARS-CoV-2 virus from dry nasal swabs (NS) from human patients with signs and symptoms during the acute phase of respiratory tract infection in conjunction with clinical and epidemiological risk factors.

The LIAISON® NES FLU A/B, RSV & COVID-19 assay is intended for use as an aid in the differential diagnosis of influenza A, influenza B, RSV and SARS-CoV-2 infection in a professional laboratory setting.

Negative results do not preclude influenza A, influenza B, RSV or SARS-CoV-2, infection and should not be used as the sole basis for patient management decisions. The assay is not intended to detect the presence of the influenza C virus.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Participants are not provided investigational results and will only be provided with routine standard of care diagnostics results.

入排标准

性别
All
接受健康志愿者

入选标准

  • The specimen is a NPS or NS from a patient collected and preserved in 3 mL Universal Transport Media (UTM), BD Universal Viral Transport (UVT), or MicroTest M4RT transport media, or 1 mL Copan Eswab (Liquid Amies).
  • The specimen is from a patient who is either hospitalized, admitted to a hospital emergency department, visiting an outpatient clinic or resident of a long-term care facility.
  • The specimen is from a human patient with active signs and symptoms of respiratory tract infection at time of collection
  • Specimen stored at 2-8°C for up to 72 hours from collection. If there is a delay in testing, store specimen at ≤-70 °C.
  • The total volume of the leftover specimen received is ≥1.5 mL, except for specimens collected in Liquid Amies which requires a total leftover volume of ≥0.5 mL
  • The specimen was received in good condition (no leakage or drying of the specimen).

排除标准

  • Incorrect swab type
  • Incorrect transport media
  • Incorrect specimen handling (e.g. specimens not stored at recommended temperature)
  • The specimen has undergone more than two freeze/thaw cycles
  • Specimens collected with calcium alginate or organic swabs

结局指标

主要结局

Diagnostic Accuracy

时间窗: Samples will be tested on LIAISON NES within two hours of collection.

Estimates of Sensitivity/percent positive agreement (PPA) and Specificity/percent negative agreement (NPA) will be calculated based on a two-by-two table (comparator method result vs. result from LIAISON® NES FLU A/B, RSV \& COVID-19 assay or LIAISON PLEX® RSP Flex assay) for each target. In addition, 95% two-sided confidence intervals will be provided. A separate Sensitivity/PPA and Specificity/NPA for each target, to include those specimens excluded due to a discrepancy between the standard-of-care and molecular comparator result, will be presented in a separate 2 x 2 table.

次要结局

  • Clinical Performance(Samples will be tested on LIAISON NES within one hour of collection.)

研究者

发起方
DiaSorin Molecular LLC
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验